The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Metabolic Factors Associated with Benign Prostatic Hyperplasia
Open accessAbstract
Context: Benign prostatic hyperplasia poses a significant public health problem, but its etiology remains unclear. Obesity and associated abnormalities in glucose homeostasis may play a role in benign prostatic hyperplasia development by influencing prostate growth. Objective: The objective of this study was to determine whether obesity, fasting plasma glucose concentration, and diabetes are associated with radiologically determined prostate enlargement, an objective measure of benign prostatic hyperplasia. Design: This study was a cross-sectional analysis with robust variance estimates to account for multiple measures over time in the same individuals. Setting: This prospective cohort study was composed of community volunteers. Patients: Patients studied were 422 adult men enrolled in The Baltimore Longitudinal Study of Aging. Main Outcome Measurements: Total prostate volume as determined by pelvic magnetic resonance imaging was measured. Results: Among 422 participants, 91 (21.6%) had prostate enlargement (defined as total prostate volume ≥ 40 cc) at first visit. Compared with men of normal weight [body mass index (BMI) < 25 kg/m2], the age-adjusted odds ratio (OR) for prostate enlargement for overweight men (BMI, 25–29.9 kg/m2) was 1.41 (95% CI, 0.84–2.37), for obese men (BMI, 30–34 kg/m2) was 1.27 (95% CI, 0.68–2.39), and for severely obese men (BMI ≥ 35 kg/m2) was 3.52 (95% CI, 1.45–8.56) (P = 0.01). Men with elevated fasting glucose (>110 mg/dl) were more likely to have an enlarged prostate than men with normal fasting glucose (≤110 mg/dl) (OR, 2.98; 95% CI, 1.70–5.23), as were men with a diagnosis of diabetes (OR, 2.25; 95% CI, 1.23–4.11). Conclusions: Obesity, elevated fasting plasma glucose, and diabetes are risk factors for benign prostatic hyperplasia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 1×
“Obesity and elevated fasting glucose are components of the metabolic syndrome (11); both obesity and the metabolic syndrome are associated with systemic inflammation and oxidative stress (48).”
BackgroundDong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“Free testosterone index, which correlates highly with serum free testosterone (39, 40) and is an indicator of the amount of serum testosterone able to diffuse into the prostate, was calculated as the molar ratio of testosterone to SHBG.”
BackgroundThe American Urological Association Symptom Index for Benign Prostatic Hyperplasia
Barry, M. J., Fowler, F. J., O’Leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K., Cockett, A. T. K., & The Measurement Committee of the American Urological Association (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)36966-5 · Cited by 3,436
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760 · cited 2×
“Serum testosterone and SHBG concentrations were determined as described previously (31).”
MethodSelf-citationRegression standard errors in clustered samples
Rogers, W. H. (1993) · Stata technical bulletin · Cited by 2,694
A Note on Robust Variance Estimation for Cluster‐Correlated Data
Williams, R. L. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00645.x · Cited by 2,501 · cited 1×
“Generalized estimating equations regression modeling (linear for prostate volume and lower urinary tract symptom score and logistic for prostate enlargement and high-moderate to severe lower urinary tract symptoms) was performed with robust variance estimates to account for multiple measures over time in the same indi…”
MethodMcConnell, J. D., Roehrborn, C. G., Bautista, O. M., Andriole, G. L., Dixon, C. M., Kusek, J. W., Lepor, H., McVary, K. T., Nyberg, L. M., Clarke, H. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030656 · Cited by 2,043
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
Barry, M. J., Fowler, F. J., O'leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K., Cockett, A. T. K., & Measurement Committee of the American Urological Association (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.071 · Cited by 1,940
Nelson, W. G., De Marzo, A. M., & Isaacs, W. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021562 · Cited by 918
AUA PRACTICE GUIDELINES COMMITTEE (2003) · Journal of Urology · doi:10.1097/01.ju.0000078083.38675.79 · Cited by 844
The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
Khandwala, H. M., McCutcheon, I. E., Flyvbjerg, A., & Friend, K. E. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0399 · Cited by 843
Normal Human Aging: The Baltimore Longitudinal Study on Aging
Shock, N. W., Greulich, R. C., Costa, P. T., Andres, R., Lakatta, E. G., Arenberg, D., & Tobin, J. D. (1984) · University Libraries (University of Maryland) · doi:10.13016/sclw-iccq · Cited by 750
Effects of exercise and diet on chronic disease
Roberts, C. K., & Barnard, R. J. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00852.2004 · Cited by 556
Normal Human Aging: The Baltimore Longitudinal Study of Aging
(1985) · Journal of Gerontology · doi:10.1093/geronj/40.6.767 · Cited by 474
Benign prostatic hyperplasia: an overview
Ziada, A., Rosenblum, M., & Crawford, E. D. (1999) · Urology · doi:10.1016/s0090-4295(98)00532-9 · Cited by 431
Epidemic Obesity and the Metabolic Syndrome
Haffner, S., & Taegtmeyer, H. (2003) · Circulation · doi:10.1161/01.cir.0000088845.17586.ec · Cited by 427
The pathogenesis of benign prostatic hyperplasia
Wilson, J. D. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90267-3 · Cited by 355
COHEN, P., PEEHL, D. M., LAMSON, G., & ROSENFELD, R. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-401 · Cited by 355
Meigs, J. B., Mohr, B., Barry, M. J., Collins, M. M., & McKinlay, J. B. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00351-1 · Cited by 338
Roehrborn, C. G., McConnell, J. D., Lieber, M., Kaplan, S., Geller, J., Malek, G. H., Castellanos, R., Coffield, S., Saltzman, B., Resnick, M., et al. (1999) · Urology · doi:10.1016/s0090-4295(98)00654-2 · Cited by 333
THE DEVELOPMENT OF BENIGN PROSTATIC HYPERPLASIA AMONG VOLUNTEERS IN THE NORMATIVE AGING STUDY
(1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113986 · Cited by 323
Hammarsten, J., Högstedt, B., Holthuis, N., & Mellström, D. (1998) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500221 · Cited by 323
Asymptomatic inflammation and/or infection in benign prostatic hyperplasia
Nickel, Downey, Young, & Boag (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00352.x · Cited by 319
Hyperinsulinaemia as a Risk Factor for Developing Benign Prostatic Hyperplasia
Hammarsten, J., & Högstedt, B. (2001) · European Urology · doi:10.1159/000052430 · Cited by 310
Miller, K. K., Rosner, W., Lee, H., Hier, J., Sesmilo, G., Schoenfeld, D., Neubauer, G., & Klibanski, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030680 · Cited by 301
Silverio, F. D., Gentile, V., Matteis, A. D., Mariotti, G., Voria, G., Pastore, A. L., & Sciarra, A. (2003) · European Urology · doi:10.1016/s0302-2838(02)00548-1 · Cited by 277
Relation of Body Mass Index in Young Adulthood and Middle Age to Medicare Expenditures in Older Age
Daviglus, M. L. (2004) · JAMA · doi:10.1001/jama.292.22.2743 · Cited by 243
Dahle, S. E., Chokkalingam, A. P., Gao, Y.-T., Deng, J., Stanczyk, F. Z., & Hsing, A. W. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64687-3 · Cited by 241
Roehrborn, C. G., Boyle, P., Bergner, D., Gray, T., Gittelman, M., Shown, T., Melman, A., Bracken, R. B., deVere White, R., Taylor, A., et al. (1999) · Urology · doi:10.1016/s0090-4295(99)00232-0 · Cited by 233
Clinical and Experimental Studies of Benign Prostatic Hyperplasia
Coffey, D. S., & Walsh, P. C. (1990) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)00960-5 · Cited by 228
Obesity and Benign Prostatic Hyperplasia
Giovannucci, E., Rimm, E. B., Chute, C. G., Kawachi, I., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117206 · Cited by 226
Wang, W., Bergh, A., & Damber, J. (2004) · The Prostate · doi:10.1002/pros.20061 · Cited by 204
Synthesis and regulation of sex hormone-binding globulin in obesity
Hautanen, A. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801281 · Cited by 172
Blake, D. R., Meigs, J. B., Muller, D. C., Najjar, S. S., Andres, R., & Nathan, D. M. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2095 · Cited by 169 · cited 3×
“Fasting plasma glucose concentration was determined as described previously (30).”
MethodInfluentialPlatz, E. A., Smit, E., Curhan, G. C., Nyberg, L. M., & Giovannucci, E. (2002) · Urology · doi:10.1016/s0090-4295(01)01673-9 · Cited by 158
Self-citationPhysical Activity and Benign Prostatic Hyperplasia
Platz, E. A., Kawachi, I. I., Rimm, E. B., Colditz, G. A., Stampfer, M. J., Willett, W. C., & Giovannucci, E. L. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.21.2349 · Cited by 157
Self-citationProstate Volume and Serum Prostate–Specific Antigen as Predictors of Acute Urinary Retention
Marberger, M., Andersen, J., Nickel, J. C., Malice, M., Gabriel, M., Pappas, F., Meehan, A., Stoner, E., & Waldstreicher, J. (2000) · European Urology · doi:10.1159/000020356 · Cited by 149
Rohrmann, S. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh060 · Cited by 135
Shibata, Y., Ito, K., Suzuki, K., Nakano, K., Fukabori, Y., Suzuki, R., Kawabe, Y., Honma, S., & Yamanaka, H. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000101)42:1<45::aid-pros6>3.0.co;2-w · Cited by 126
Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia
Suzuki, S., Platz, E. A., Kawachi, I. I., Willett, W. C., & Giovannucci, E. L. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.4.689 · Cited by 125
Self-citationEthnicity and Migration as Determinants of Human Prostate Size
Jin, B., Turner, L., Zhou, Z., Zhou, E. L., & Handelsman, D. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3613 · Cited by 91
RACE, ETHNICITY AND BENIGN PROSTATIC HYPERPLASIA IN THE HEALTH PROFESSIONALS FOLLOW-UP STUDY
Platz, E. A., Kawachi, I. I., Rimm, E. B., Willett, W. C., & Giovannucci, E. L. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67909-8 · Cited by 82
Self-citationWright, E. J., Fang, J., Metter, E. J., Partin, A. W., Landis, P., Chan, D. W., & Carter, H. B. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)65010-0 · Cited by 60
Self-citationRelationship of serum sex‐steroid hormones and prostate volume in African American men
Joseph, M., Wei, J. T., Harlow, S. D., Cooney, K. A., Dunn, R. L., Jaffe, C. A., Montie, J. E., & Schottenfeld, D. (2002) · The Prostate · doi:10.1002/pros.10154 · Cited by 58
Prostatic Growth Rate Determined from MRI Data: Age‐Related Longitudinal Changes
Williams, A. M., Simon, I., Landis, P., Moser, C., Christens‐Barry, W. A., CARTER, H. B., Metter, E. J., & Partin, A. W. (1999) · Journal of Andrology · doi:10.1002/j.1939-4640.1999.tb02545.x · Cited by 57
Self-citationOptimising the Medical Management of Benign Prostatic Hyperplasia
Marberger, M., Harkaway, R. C., & de la Rosette, J. J. M. C. H. (2003) · European Urology · doi:10.1016/j.eururo.2003.10.016 · Cited by 46
Larger Prostatic Adenomas in Obese Men with No Associated Increase in Obstructive Uropathy
Daniell, H. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)36067-6 · Cited by 40
Mochtar, C. A., Kiemeney, L. A. L. M., Laguna, M. P., van Riemsdijk, M. M., Barnett, G. S., Debruyne, F. M. J., & de la Rosette, J. J. M. C. H. (2005) · Urology · doi:10.1016/j.urology.2004.09.030 · Cited by 28
Cited by
Chughtai, B., Forde, J. C., Thomas, D. D. M., Laor, L., Hossack, T., Woo, H. H., Te, A. E., & Kaplan, S. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.31 · Cited by 462
The Correlation Between Metabolic Syndrome and Prostatic Diseases
De Nunzio, C., Aronson, W., Freedland, S. J., Giovannucci, E., & Parsons, J. K. (2012) · European Urology · doi:10.1016/j.eururo.2011.11.013 · Cited by 368
Self-citationBenign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors
Parsons, J. K. (2010) · Current Bladder Dysfunction Reports · doi:10.1007/s11884-010-0067-2 · Cited by 325
Self-citationPrevalence and Trends of Urinary Incontinence in Adults in the United States, 2001 to 2008
Markland, A. D., Richter, H. E., Fwu, C.-W., Eggers, P., & Kusek, J. W. (2011) · Journal of Urology · doi:10.1016/j.juro.2011.03.114 · Cited by 283
Risk of cancer in a large cohort of U.S. veterans with diabetes
Atchison, E. A., Gridley, G., Carreon, J. D., Leitzmann, M. F., & McGlynn, K. A. (2011) · International Journal of Cancer · doi:10.1002/ijc.25362 · Cited by 257
Metadata
- Authors
- Parsons, J. K., Carter, H. B., Partin, A. W., Windham, B. G., Metter, E. J., Ferrucci, L., Landis, P., & Platz, E. A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-07-01
- Volume
- 91
- Issue
- 7
- Pages
- 2562-2568
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2131627141
- Cited by
- 336
- References
- 54
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.